Image analysis – Applications – Biomedical applications
Reexamination Certificate
2011-03-15
2011-03-15
Ahmed, Samir A (Department: 2624)
Image analysis
Applications
Biomedical applications
Reexamination Certificate
active
07907759
ABSTRACT:
Physician interactive workstations with global cardiac voxel distribution visualization may also include one or more of a 3-D color scale image of a population of voxel in the heart and/or an electronic boundary-tracing tool configured to accept user input to electronically define at least one boundary of a target region of a heart in a medical image of a patient on a display. The workstation may be configured to evaluate intensity of voxels associated with tissue within the defined boundary of the target region of the heart whereby cardiotoxicity is evaluated.
REFERENCES:
patent: 5333244 (1994-07-01), Harashima
patent: 6368285 (2002-04-01), Osadchy et al.
patent: 7106892 (2006-09-01), Breeuwer et al.
patent: 7258670 (2007-08-01), Bardy
patent: 7301016 (2007-11-01), Meyers et al.
patent: 7333845 (2008-02-01), Hundley et al.
patent: 7396654 (2008-07-01), Hayes et al.
patent: 7747308 (2010-06-01), Hundley et al.
patent: 2005/0075567 (2005-04-01), Skyba et al.
patent: 2005/0215883 (2005-09-01), Hundley et al.
patent: WO2004/026140 (2004-04-01), None
patent: WO2005/077263 (2005-08-01), None
International Search Report and Written Opinion dated Sep. 12, 2007 for corresponding PCT application No. PCT/US2007/001927.
Heiberg, E., XP-002449063,Automated Feature Detection in Multidimensional Images, pp. 1-149, Linköping Dec. 2004.
Able Software Corp., XP-002449130,3D-Doctor Overview and Tutorial, pp. 15-129, Oct. 16, 2003.
U.S. Appl. No. 11/346,527, filed Feb. 2, 2006, Hundley et al.
“General Principals of Software Validation; Final Guidance for Industry and FDA Staff” U.S. Dept of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics and Evaluation Research, 47 pages (Jan. 11, 2002).
Bellenger et al. “Reduction in Sample Size for Studies of Remodeling in Heart Failure by the Use of Cardiovascular Magnetic Resonance”J Cardiovascular Mangn Reson2(4): 271-278 (2000) (Abstract).
Bristow et al. “Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac Catheterization”Annals of Internal Medicine88: 168-175 (1978).
Cardinale et al. “Myocardial Injury Revealed by Plasma Troponin I in Breast Cancer Treated with High-Dose Chemotherapy”Annals of Oncology13: 710-715 (2002).
Cerqueira et al. “Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart: A Statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clincial Cardiology of the American Heart Association”Circulation150: 539-542 (2002).
Choi et al. “Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function”Circulation104: 1101-1107 (2001).
Chuang et al. “Importance of Imaging Method Over Imaging Modality in Noninvasive Determination of Left Ventricular Volumes and Ejection Fraction: Assessment by Two- and Three-Dimensional Echocardiography and Magnetic Resonance Imaging”Journal of the American College of Cardiology35(2): 477-484 (2000).
Darty et al. “Nursing Responsibilities During Cardiac Magnetic Resonance Imaging” Department of Internal Medicine (Cardiology Section) and Radiology at the Wake Forest University School of Medicine (believed to be before Feb. 6, 2004).
Del Carlo et al. “Cardiac Troponins in Congestive Heart Failure”American Heart Journal138: 646-653 (1999).
Dombernowsky et al. “Doxorubicin and Paclitaxel, a Highly Active Combination in the Treatment of Metastatic Breast Cancer”Seminars in Oncology23(5 suppl 11): 23-27 (1996).
Gehl et al. “Paclitaxel and Doxorubicin in Metastatic Breast Cancer”Seminars in Oncology23(6 suppl 15): 35-38 (1996).
Gerber et al. “Relation Between Gd-DTPA Contrast Enhancement and Regional Inotropic Response in the Periphery and Center of Myocardial Infarction”Circulation104:998-1004 (2001).
Gerber et al. “Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction”, Circulation, vol. 106, No. 9, pp. 1083-1089, (Aug. 27, 2002).
Gianni et al. “Cardiac Function Following Combination Therapy with Taxol (T) and Doxorubicin (A) for Advanced Breast Cancer (ABC)”Proceedings of ASCOvol. 17 (1998) (Abstract).
Gianni et al. “Paclitaxel by 3-Hour Infusion in Combination with Bolus Doxorubicin in Women with Untreated Metastatic Breast Cancer: High Antitumor Efficacy and Cardiac Effects in a Dose-Finding and Sequence-Finding Study”Journal of Clinical Oncology13(11): 2688-2699 (1995).
Gottdiener et al. “Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction by Radionuclide Cineangiography”Annals of Internal Medicine94(part 1): 430-435 (1981).
Hamilton et al. “Is Imaging at Intermediate Doses Necessary During Dobutamine Stress Magnetic Resonance Imaging?”Journal of Cardiovascular Magnetic Resonance3(4): 297-302 (2001).
Hochster et al. “Cardiotoxicity and Cardioprotection During Chemotherapy”Current Science7: 304-309 (1995).
Hortobagyi “Treatment of Breast Cancer”The New England Journal of Medicine339(14): 974-984(1998).
Hundley et al. “Magnetic Resonance Imaging Determination of cardiac Prognosis”Circulation106: 2328-2333 (2002).
Hundley et al. “Magnetic Resonance Imaging Assessment of the Severity of Mitral Regurgitation: Comparison with Invasive Techniques”Circulation92: 1151-1158 (1995).
Hundley et al. “Relation of Cardiac Prognosis to Segment Location with Apical Left Ventricular Ischemia”The American Journal of Cardiology92: 1206-1208 (2003).
Hundley et al. “Utility of Fast Cine Magnetic Resonance Imaging an display for the Detection of Myocardial Ischemia in patients Not Well Suited for Second Harmonic Stress Echocardiography”Circulation100: 1697-1702 (1999).
International Search Report and Written Opinion for PCT/US2006/003763; mailed May 30, 2005.
Jacobson et al. “Magnetic Resonance Imaging of the Cardiovascular System: Present State of the Art and Future Potential”JAMA259(2): 253-259 (1988).
Jensen et al. “Functional Monitoring of Anthracycline Cardiotoxicity: A Prospective, Blinded, Long-Term Observational Study of Outcome in 120 Patients”Annals of Oncology13: 699-709 (2002).
Judd et al. “Physiological basis of Myocardial Contrast Enhancement in Fast Magnetic Resonance Images of 2-Day-Old Reperfused Canine Infarcts”Circulation92: 1902-1910 (1995).
Kellman et al. “Phase-Sensitive Inversion Recover for Detecting Myocardial Infarction Using Gadolinium-Delayed Hyperenhancement”Magnetic Resonance in Medicine47: 372-383 (2002).
Kim et al. “The Use of Contract-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction”New England Journal of Medicine343: 1445-1453 (2000).
Leandro et al. “Cardiac Dysfunction Late After Cardiotoxic Therapy for Childhood Cancer”The American Journal of Cardiology74:1152-1156 (1994).
Lebwhol et al. “New Developments in Chemotherapy of Advanced Breast Cancer”Annals of Oncology10(suppl 6): S139-S146 (1999).
Lipshultz et al. “Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood”The New England Journal of Medicine324(12): 808-815 (1991).
Longmore et al. “Dimensional Accuracy of Magnetic Resonance in Studies of the Heart”The Lancetpp. 1360-1362 (Jun. 15, 1985).
Lorenz et al. “Normal Human Right and Left Ventricular Mass, Systolic Function, and Gender Differences by Cine Magnetic Resonance Imaging”J Cardiovascular Magn Reson1(1): 7-21 (1999) (Abstract).
Maisel et al. “B-Type Natriuretic Peptide Levels: Diagnostic and Prognostic in Congestive Heart Failure: What's Next?”Circulation150: 2328-2331 (2002).
Martin et al. “
D'Agostino Ralph B.
Hamilton Craig A.
Hundley William Gregory
Ahmed Samir A
Fitzpatrick Atiba O
Myers Bigel Sibley & Sajovec P.A.
Wake Forest University Health Sciences
LandOfFree
Cardiac visualization systems for displaying 3-D images of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiac visualization systems for displaying 3-D images of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiac visualization systems for displaying 3-D images of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2719419